Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model

Cancer Investigation

Volumn 29, Issue 3, 2011, Pages 240-245

  Chang, Simon ^a   Iversen, Lars ^a   Kragballe, Knud ^a   Arthur, J Simon C ^b   Johansen, Claus ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Carcinogenesis; Gene expression; Signal transduction

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN; SKIN CANCER; SKIN CARCINOGENESIS; STRAIN DIFFERENCE; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 79951618058     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.550594     Document Type: Article

References (23)

1. Deak M, Clifton AD, Lucocq LM, Alessi DR. Mitogen-and stressactivated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 1998;17:4426-4441. (Pubitemid 28362632)
2. Pierrat B, Correia JS, Mary JL, Tomas-Zuber M, Lesslauer W. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogenactivated protein kinase (p38alphaMAPK). J Biol Chem 1998;273:29661-29671. (Pubitemid 28509976)
3. Arthur JS. MSK activation and physiological roles. Front Biosci 2008;13:5866-5879.
4. McCoy CE, Campbell DG, Deak M, Bloomberg GB, Arthur JS. MSK1 activity is controlled by multiple phosphorylation sites. Biochem J 2005;387:507-517. (Pubitemid 40571238)
5. Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG, Iversen L, Arthur JS. The kinases MSK1 and MSK2 act as negative regulators of Tolllike receptor signaling. Nat Immunol 2008;9:1028-1036.
6. Tomas-Zuber M, Mary JL, Lamour F, Bur D, Lesslauer W. Cterminal elements control location, activation threshold, and p38 docking of ribosomal S6 kinase B (RSKB). J Biol Chem 2001;276:5892-5899.
7. Tomas-Zuber M, Mary JL, Lesslauer W. Control sites of ribosomal S6 kinase B and persistent activation through tumor necrosis factor. J Biol Chem 2000;275:23549-23558. (Pubitemid 30624637)
8. Janknecht R. Regulation of the ER81 transcription factor and its coactivators by mitogen-and stress-activated protein kinase 1 (MSK1). Oncogene 2003;22:746-755. (Pubitemid 36269288)
9. Vesely PW, Staber PB, Hoefler G, Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat Res 2009;682:7-12.
10. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001;2:599-609. (Pubitemid 33674011)
11. Schiller M, Bohm M, Dennler S, Ehrchen JM, Mauviel A. Mitogen-and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated C-fos gene expression in keratinocytes. Oncogene 2006;25:4449-4457. (Pubitemid 44141633)
12. Kim HG, Lee KW, Cho YY, Kang NJ, Oh SM, Bode AM, Dong Z. Mitogen-and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res 2008;68:2538-2547. (Pubitemid 351521831)
13. Mueller MM. Inflammation in epithelial skin tumours: old stories and new ideas. Eur J Cancer 2006;42:735-744.
14. De Giorgi V, Salvini C, Chiarugi A, Paglierani M, Maio V, Nicoletti P, Santucci M, Carli P, Massi D. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma. Int J Dermatol 2009;48:312-321.
15. Lacarrubba F, Nasca MR, Micali G. Advances in the use of topical imiquimod to treat dermatologic disorders. Ther Clin RiskManag 2008;4:87-97. (Pubitemid 351460934)
16. Cohen P. Targeting protein kinases for the development of antiinflammatory drugs. Curr Opin Cell Biol 2009;21:317-324.
17. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. MSK1 and MSK2 are required for the mitogen-and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 2002;22:2871-2881. (Pubitemid 34263007)
18. Funding AT, Johansen C, Gaestel M, Bibby BM, Lilleholt LL, Kragballe K, Iversen L. Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice. J Invest Dermatol 2009;129:891-898.
19. Otkjaer K, Kragballe K, Johansen C, Funding AT, Just H, Jensen UB, Sorensen LG, Norby PL, Clausen JT, Iversen L. IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms. J Invest Dermatol 2007;127:1326-1336. (Pubitemid 46762975)
20. Schindler EM, Hindes A, Gribben EL, Burns CJ, Yin Y, Lin MH, Owen RJ, Longmore GD, Kissling GE, Arthur JS, Efimova T. p38delta mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res 2009;69:4648-4655.
21. Johansen C, Vestergaard C, Kragballe K, Kollias G, Gaestel M, Iversen L. MK2 regulates the early stages of skin tumor promotion. Carcinogenesis 2009;30:2100-2108.
22. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007;408:297-315.
23. Hirasawa N, Ohsawa Y, Ishihara K, Seyama T, Hong J, Ohuchi K. Analysis of themechanism for the development of allergic skin inflammation and the application for its treatment: establishment of a modified allergic dermatitis model in mouse ear lobes by application of 12-O-tetradecanoyl phorbol 13-acetate: putative involvement of thymic stromal lymphopoietin and roles of histamine. J Pharmacol Sci 2009;110:245-250.